Novo Nordisk projects weaker sales as it battles copycat drugs
Novo Nordisk projects weaker sales as it battles copycat drugshttps://wpnnradio.com/wp-content/themes/movedo/images/empty/thumbnail.jpg150150adminadminhttps://secure.gravatar.com/avatar/790df65a416873c3f0501d984b0b24a2f32bf2af0d1509085b901ade4bbb36e7?s=96&d=mm&r=g
Novo Nordisk said it expects weaker sales growth of its popular weight-loss drug Wegovy due to competition from copycat drugs. source
